Contact
searchSearch
HMP Global
Login

Opioid Use Disorder Topic Center

Featured

ASAM
Conference Coverage
ASAM 2026 to Showcase Transformative Care Models for Addiction, Psychiatric Comorbidities
04/23/2026
Brionna Mendoza
At the American Society of Addiction Medicine (ASAM) 2026 Annual Conference, hosted in San Diego on April 23-26, 2026, clinicians will explore numerous emerging strategies addressing substance use disorders (SUDs)
At the American Society of Addiction Medicine (ASAM) 2026 Annual Conference, hosted in San Diego on April 23-26, 2026, clinicians will explore numerous emerging strategies addressing substance use disorders (SUDs)
At the American Society of...
04/23/2026
Psych Congress Network
NYSAM 2026 Meeting Logo
Conference Coverage
NYSAM 2026 Spotlights Harm Reduction, Psychiatric Care in SUD Treatment
03/17/2026
Brionna Mendoza
At the 2026 New York Society of Addiction Medicine (NYSAM) Annual Conference in New York, clinicians and policymakers focused on integrating evolving policy with patient-centered addiction care.
At the 2026 New York Society of Addiction Medicine (NYSAM) Annual Conference in New York, clinicians and policymakers focused on integrating evolving policy with patient-centered addiction care.
At the 2026 New York Society of...
03/17/2026
Psych Congress Network
Evguenia Makovkina, MD
Conference Coverage
Education Intervention Boosts Psychiatrists’ Knowledge and Attitudes on mOUD
03/07/2026
Evguenia Makovkina, MD
Evguenia Makovkina, MD, discusses key findings from her pilot study examining psychiatrists’ baseline knowledge, attitudes, and prescribing practices related to medications for opioid use disorder (mOUD).
Evguenia Makovkina, MD, discusses key findings from her pilot study examining psychiatrists’ baseline knowledge, attitudes, and prescribing practices related to medications for opioid use disorder (mOUD).
Evguenia Makovkina, MD,...
03/07/2026
Psych Congress Network
pills spilling out of a tipped over pill bottle
News
Health Plan Disenrollment After MOUD Initiation Tied to Higher Mortality in US Cohort
03/05/2026
Maria Mantas
Health plan disenrollment after initiation of medications for opioid use disorder (MOUD) was associated with significantly increased all-cause and overdose mortality in a recent cohort study.
Health plan disenrollment after initiation of medications for opioid use disorder (MOUD) was associated with significantly increased all-cause and overdose mortality in a recent cohort study.
Health plan disenrollment after...
03/05/2026
Psych Congress Network
a group of clinicians
News
Collaborative Care Shows No Added Benefit for OUD With Depression or PTSD
01/02/2026
Maria Mantas
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model...
01/02/2026
Psych Congress Network
a pencil on a paper quiz
Quiz
Self-Reported Rates of Illicitly Manufactured Fentanyl Use
06/11/2025
Maria Mantas
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data...
06/11/2025
Psych Congress Network
pills
News
Prevalence of Illicit Opioid Use Higher Than Previously Estimated
06/04/2025
Maria Mantas
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use,...
06/04/2025
Psych Congress Network
woman practicing mindfulness
News
Mindfulness Training Restores Reward System Function, Reduces Cravings, in OUD
06/02/2025
Jolynn Tumolo
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training...
06/02/2025
Psych Congress Network
illustration of a quiz on a clipboard
Quiz
Using Appropriate Terminology for Pharmacologic OUD Treatment
05/14/2025
Maria Mantas
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American...
05/14/2025
Psych Congress Network
doctor looks through medical records
News
Automated Technique Identifies Problematic Opioid Use From EHR Notes
05/05/2025
Jolynn Tumolo
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that...
05/05/2025
Psych Congress Network
patient taking pills
News
Low-Dose Buprenorphine Initiation May Prevent Opioid Withdrawal in Some Patients
04/28/2025
Jolynn Tumolo
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received...
04/28/2025
Psych Congress Network

News

a group of clinicians
News
Collaborative Care Shows No Added Benefit for OUD With Depression or PTSD
01/02/2026
Maria Mantas
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model...
01/02/2026
Psych Congress Network
pills
News
Prevalence of Illicit Opioid Use Higher Than Previously Estimated
06/04/2025
Maria Mantas
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use,...
06/04/2025
Psych Congress Network
woman practicing mindfulness
News
Mindfulness Training Restores Reward System Function, Reduces Cravings, in OUD
06/02/2025
Jolynn Tumolo
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training...
06/02/2025
Psych Congress Network
doctor looks through medical records
News
Automated Technique Identifies Problematic Opioid Use From EHR Notes
05/05/2025
Jolynn Tumolo
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that...
05/05/2025
Psych Congress Network
patient taking pills
News
Low-Dose Buprenorphine Initiation May Prevent Opioid Withdrawal in Some Patients
04/28/2025
Jolynn Tumolo
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received...
04/28/2025
Psych Congress Network
an assortment of pills spilled out on a yellow table
News
Inpatient Addiction Consultation Service Promotes MOUD in Patients With OUD
04/14/2025
Jolynn Tumolo
According to randomized clinical trial findings, patients with opioid use disorder (OUD) who received inpatient addiction consultation service were more likely to initiate medication for OUD (MOUD) compared to those who received usual care.
According to randomized clinical trial findings, patients with opioid use disorder (OUD) who received inpatient addiction consultation service were more likely to initiate medication for OUD (MOUD) compared to those who received usual care.
According to randomized clinical...
04/14/2025
Psych Congress Network
open and spilled bottle of pills
News
US Drug Overdose Deaths Show Steep Decline in Most Recent Data
04/07/2025
Jolynn Tumolo
Drug overdose deaths dropped almost 24% in the US for the 12 months ending in September 2024 compared with the previous year, according to provisional data from the Centers for Disease Control and Prevention (CDC).
Drug overdose deaths dropped almost 24% in the US for the 12 months ending in September 2024 compared with the previous year, according to provisional data from the Centers for Disease Control and Prevention (CDC).
Drug overdose deaths dropped...
04/07/2025
Psych Congress Network
US FDA sign
News
FDA Seeks Clearer Labeling for Transmucosal Buprenorphine Product Dosing
03/24/2025
Jolynn Tumolo
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that...
03/24/2025
Psych Congress Network
emergency room hospital waiting room reception area
News
Why Aren’t More Emergency Departments Using Medications for OUD Treatment?
03/12/2025
Jolynn Tumolo
Barriers may be hampering the use of medications for opioid use disorder (MOUD) in US emergency departments (EDs), according to results from a systematic review published in the Journal of Substance Use & Addiction Treatment.
Barriers may be hampering the use of medications for opioid use disorder (MOUD) in US emergency departments (EDs), according to results from a systematic review published in the Journal of Substance Use & Addiction Treatment.
Barriers may be hampering the...
03/12/2025
Psych Congress Network
Opioid Use Disorder Incidence Declines After State Policy Limits Opioid Prescriptions
News
Opioid Use Disorder Incidence Declines After State Policy Limits Opioid Prescriptions
02/24/2025
Jolynn Tumolo
New diagnoses of opioid use disorder in Vermont steadily lessened, most noticeably in young adults, after the state limited opioid analgesic prescriptions for acute pain in 2017. Researchers reported their findings in the American Journal of...
New diagnoses of opioid use disorder in Vermont steadily lessened, most noticeably in young adults, after the state limited opioid analgesic prescriptions for acute pain in 2017. Researchers reported their findings in the American Journal of...
New diagnoses of opioid use...
02/24/2025
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
News
Semaglutide May Improve Motivation in MDD, Small Trial Finds
05/04/2026
Brionna Mendoza
A randomized clinical trial published in JAMA Psychiatry found that oral semaglutide may improve effort-based decision-making in adults with major depressive disorder (MDD).
A randomized clinical trial published in JAMA Psychiatry found that oral semaglutide may improve effort-based decision-making in adults with major depressive disorder (MDD).
A randomized clinical trial...
05/04/2026
Psych Congress Network
A patient receives psychedelic-assisted therapy
News
Presidential Executive Order Seeks to Expand Psychedelic Access for Tough-To-Treat Mental Illnesses
04/29/2026
Brionna Mendoza
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed...
04/29/2026
Psych Congress Network
a female soldier stands in front of a row of American flags
News
TMS Improves Residential Therapy Outcomes in Combat-Related PTSD
04/22/2026
Maria Mantas
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial...
04/22/2026
Psych Congress Network
A doctor sits at a table holding a pill bottle in one hand while filling out paperwork
News
Algorithm-Guided Treatment Improves Outcomes in Major Depressive Disorder
04/14/2026
Brionna Mendoza
A systematic review published in Frontiers in Psychiatry reports that algorithm-guided treatment (AGT) is generally associated with improved remission rates and more timely treatment modifications compared with treatment as usual (TAU).
A systematic review published in Frontiers in Psychiatry reports that algorithm-guided treatment (AGT) is generally associated with improved remission rates and more timely treatment modifications compared with treatment as usual (TAU).
A systematic review published in...
04/14/2026
Psych Congress Network
a person attempts to pick up a glass of water
News
Valbenazine Demonstrates Higher Persistence vs Deutetrabenazine in TD Patients
04/14/2026
Maria Mantas
Neurocrine Biosciences reported new real-world evidence demonstrating higher treatment persistence with valbenazine (Ingrezza) compared with deutetrabenazine (Austedo XR) among adults with tardive dyskinesia (TD).
Neurocrine Biosciences reported new real-world evidence demonstrating higher treatment persistence with valbenazine (Ingrezza) compared with deutetrabenazine (Austedo XR) among adults with tardive dyskinesia (TD).
Neurocrine Biosciences reported...
04/14/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
News
Open-Label Extension Trial Supports Long-Term Use of Viloxazine ER in Children and Adolescents
04/13/2026
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension...
04/13/2026
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News

ADHD Incidence Trends Accelerated After DSM-5 Changes and COVID-19 Disruptions
04/10/2026
Brionna Mendoza
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity...
04/10/2026
Psych Congress Network
A profile of a person split in half, one half teal and the other purple, with a swirl line over the head
News
Higher Risk of Premature Death Found in Bipolar II Disorder
04/07/2026
Brionna Mendoza
Bipolar II disorder (BD-II) is associated with significantly increased mortality, according to a large population-based cohort study published in JAMA Network Open.
Bipolar II disorder (BD-II) is associated with significantly increased mortality, according to a large population-based cohort study published in JAMA Network Open.
Bipolar II disorder (BD-II) is...
04/07/2026
Psych Congress Network
a man with depression looks out a window major depressive disorder
Research Summary
Psilocybin Produces Mixed Outcomes in Phase 2b MDD Study
04/01/2026
Brionna Mendoza
A Phase 2b randomized clinical trial found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive disorder (MDD).
A Phase 2b randomized clinical trial found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive disorder (MDD).
A Phase 2b randomized clinical...
04/01/2026
Psych Congress Network
spilled bottle of white pills
News
Tazbentetol Demonstrates Early Symptom Improvement in Phase 2 Schizophrenia Trial
04/01/2026
Maria Mantas
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2...
04/01/2026
Psych Congress Network

Quizzes

a pencil on a paper quiz
Quiz
Self-Reported Rates of Illicitly Manufactured Fentanyl Use
06/11/2025
Maria Mantas
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data...
06/11/2025
Psych Congress Network
illustration of a quiz on a clipboard
Quiz
Using Appropriate Terminology for Pharmacologic OUD Treatment
05/14/2025
Maria Mantas
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American...
05/14/2025
Psych Congress Network
a dialogue bubble with the word "quiz"
Quiz
How do inpatient addiction consultation services impact MOUD initiation?
04/21/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
04/21/2025
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
By What Percentage Did US Drug Overdose Deaths Decline in 2024?
04/10/2025
Maria Mantas
According to provisional data from the Center for Disease Control and Prevention (CDC), by what percentage did US drug overdose deaths decrease in the 12 months ending in September 2024 compared to the previous year?
According to provisional data from the Center for Disease Control and Prevention (CDC), by what percentage did US drug overdose deaths decrease in the 12 months ending in September 2024 compared to the previous year?
According to provisional data...
04/10/2025
Psych Congress Network
Did OUD diagnoses increase or decrease in VHA patients?
Quiz
Did OUD diagnoses increase or decrease in VHA patients?
02/25/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/25/2025
Psych Congress Network
How many US Psychiatric Hospitals Provided Medications for OUD?
Quiz
How many US psychiatric hospitals provided medications for OUD?
02/06/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/06/2025
Psych Congress Network
Which U.S. region saw the most fentanyl pill seizures in 2023?
Quiz
Which US region saw the most fentanyl pill seizures in 2023?
01/15/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
01/15/2025
Psych Congress Network
After how many months is 'problematic' opioid use diagnosed as OUD?
Quiz
After how many months is 'problematic' opioid use diagnosed as OUD?
12/16/2024
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/16/2024
Psych Congress Network
Were OUD treatment discontinuation rates higher with methadone?
Quiz
Were OUD treatment discontinuation rates higher with methadone?
12/04/2024
Pop quiz!
Pop quiz!
Pop quiz!
12/04/2024
Psych Congress Network
Do adults who smoke use more opioids?
Quiz
Do adults who smoke cigarettes use more opioids?
11/22/2024
Do you remember this study?
Do you remember this study?
Do you remember this study?
11/22/2024
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Mortality Risk in Bipolar II Disorder
04/30/2026
Maria Mantas
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between...
04/30/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
PGx Testing in MDD
04/27/2026
Maria Mantas
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of...
04/27/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Quiz
Test Your Knowledge—Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
Quiz
Long-Term Effects of Viloxazine ER in Treatment of Pediatric ADHD
04/23/2026
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test...
04/23/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Quiz
Why should anticholinergics be avoided in TD?
04/17/2026
Maria Mantas
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why...
04/17/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Quiz
Why should anticholinergics be avoided in TD?
04/17/2026
Maria Mantas
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why...
04/17/2026
Psych Congress Network
Edward Kaftarian, MD
Quiz
Legal Considerations in Cross-State Telepsychiatry
03/23/2026
Maria Mantas
Test your knowledge with this faculty insights quiz!
Test your knowledge with this faculty insights quiz!
Test your knowledge with this...
03/23/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Pharmacologic Intervention in Bulimia Nervosa
02/26/2026
Maria Mantas
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA...
02/26/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Intranasal Esketamine Dosage for Adult MDD
02/04/2026
Brionna Mendoza
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and...
02/04/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use